Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community

• Thérèse M. Kearns ,

  * E-mail: therese.kearns@menzies.edu.au

  Affiliation Menzies School of Health Research, Charles Darwin University, Darwin, Australia

  ⨯
• Richard Speare,

  Affiliation James Cook University, Townsville, Australia

  ⨯
• Allen C. Cheng,

  Affiliation Monash University, Melbourne, Australia

  ⨯
• James McCarthy,

  Affiliation QIMR Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Jonathan R. Carapetis,

  Affiliation Telethon Kids Institute, University of Western Australia and Princess Margaret Hospital for Children, Perth, Australia

  ⨯
• Deborah C. Holt,

  Affiliation Menzies School of Health Research, Charles Darwin University, Darwin, Australia

  ⨯
• Bart J. Currie,

  Affiliation Menzies School of Health Research, Charles Darwin University, Darwin, Australia

  ⨯
• Wendy Page,

  Affiliation Miwatj Health Aboriginal Corporation, Nhulunbuy, Australia

  ⨯
• Jennifer Shield,

  Affiliation La Trobe University, Bendigo, Australia

  ⨯
• Roslyn Gundjirryirr,

  Affiliation Menzies School of Health Research, Charles Darwin University, Darwin, Australia

  ⨯
• Leanne Bundhala,

  Affiliation Menzies School of Health Research, Charles Darwin University, Darwin, Australia

  ⨯
• Eddie Mulholland,

  Affiliation Miwatj Health Aboriginal Corporation, Nhulunbuy, Australia

  ⨯
• Mark Chatfield,

  Affiliation Menzies School of Health Research, Charles Darwin University, Darwin, Australia

  ⨯
• Ross M. Andrews

  Affiliation Menzies School of Health Research, Charles Darwin University, Darwin, Australia

  ⨯